70
Participants
Start Date
March 31, 2002
Primary Completion Date
August 31, 2002
Study Completion Date
August 31, 2002
GW-1000-02
Each actuation of GW-1000-02 (100 μl) delivered a dose containing 2.5 mg delta-9-tetrahydrocannabinol (THC) and 2.5 mg cannabidiol (CBD). The maximum permitted dose of study medication was eight actuations in any three hour period (20 mg THC/20 mg CBD) and 48 actuations in any 24 hour period (120 mg THC/120 mg CBD).
Placebo
Each actuation of placebo (100 μl) delivered the excipients only. The maximum permitted dose of study medication was eight actuations in any three hour period and 48 actuations in any 24 hour period.
James Paget Hospital, Norfolk
Lead Sponsor
Jazz Pharmaceuticals
INDUSTRY